Transcriptomic analysis and mutational status of IDH1 in paired primary-recurrent intrahepatic cholangiocarcinoma
Abstract Background Effective target therapies for intrahepatic cholangiocarcinoma (ICC) have not been identified so far. One of the reasons may be the genetic evolution from primary (PR) to recurrent (REC) tumors. We aim to identify peculiar characteristics and to select potential targets specific...
Main Authors: | C. Peraldo-Neia, P. Ostano, G. Cavalloni, Y. Pignochino, D. Sangiolo, L. De Cecco, E. Marchesi, D. Ribero, A. Scarpa, A. M. De Rose, A. Giuliani, F. Calise, C. Raggi, P. Invernizzi, M. Aglietta, G. Chiorino, F. Leone |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-06-01
|
Series: | BMC Genomics |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12864-018-4829-0 |
Similar Items
-
Assessment of a High Sensitivity Method for Identification of <i>IDH1</i> R132x Mutations in Tumors and Plasma of Intrahepatic Cholangiocarcinoma Patients
by: Caterina Peraldo-Neia, et al.
Published: (2019-03-01) -
A Novel Multidrug-Resistant Cell Line from an Italian Intrahepatic Cholangiocarcinoma Patient
by: Caterina Peraldo-Neia, et al.
Published: (2021-04-01) -
Clinical management of intrahepatic cholangiocarcinoma: surgical approaches and systemic therapies
by: Samantha M. Ruff, et al.
Published: (2024-01-01) -
<i>IDH1</i> Targeting as a New Potential Option for Intrahepatic Cholangiocarcinoma Treatment—Current State and Future Perspectives
by: Fabiana Crispo, et al.
Published: (2020-08-01) -
Proteomic analysis identifies deregulated metabolic and oxidative-associated proteins in Italian intrahepatic cholangiocarcinoma patients
by: Giuliana Cavalloni, et al.
Published: (2021-07-01)